Hostname: page-component-78c5997874-8bhkd Total loading time: 0 Render date: 2024-11-16T14:37:13.879Z Has data issue: false hasContentIssue false

Consensus Statements On Cognitive Dysfunction In Depression In The Uk: Rationale And Process For Gaining Consensus

Published online by Cambridge University Press:  23 March 2020

A.H. Young*
Affiliation:
Institute of Psychiatry, Psychology and Neuroscience IoPPN, Psychological Medicine, London, United Kingdom
K. Bones
Affiliation:
Sussex Partnership NHS Foundation Trust, Occupational Therapy and Recovery Practice, Sussex, United Kingdom
G. Goodwin
Affiliation:
Oxford University, Department of Psychiatry, Oxford, United Kingdom
J. Harrison
Affiliation:
VU University Medical Center, Alzheimer Center, Amsterdam, Netherlands
C. Katona
Affiliation:
University College London, Psychiatry of the Elderly, London, United Kingdom
H. McAllister-Williams
Affiliation:
Institute of Neuroscience, Newcastle University, Academic Psychiatry and Regional Affective Disorders Service, Newcastle, United Kingdom
J. Rasmussen
Affiliation:
Moat House Clinic, General Practice, Surrey, United Kingdom
S. Strong
Affiliation:
Depression Alliance, Support Group, Croydon, United Kingdom
*
*Corresponding author.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Introduction

Cognitive dysfunction is an important aspect of depression that includes problems with thinking, concentration and memory. Research suggests that the cognitive aspect of depression is highly prevalent and has a significant impact on patient functioning. Currently, cognitive dysfunction in depression is largely unrecognised, unmonitored and untreated.

Aims

We aim to define cognitive dysfunction in clinical depression (major depressive disorder) and explore its detection and management in the UK, highlighting priority areas to be addressed.

Methods

A modified Delphi method was used as the process to gain consensus. A multi-stakeholder steering committee of depression experts (including psychiatrists, psychologists, primary care physicians, and representatives from occupational therapy and a depression charity) provided the key themes and, through round-table discussion, developed draft statements. The main areas of focus were burden, detection and management of cognitive dysfunction in depression. These statements formed a questionnaire to be reviewed by 150–200 health-care professionals with an involvement in the management of depression, with level of agreement noted as ‘strongly disagree’, ‘disagree’, ‘don’t know/uncertain’, ‘agree’ or ‘strongly agree’. Responses to the questionnaire will be analysed (very high agreement [> 66%] or very low agreement [< 33%]) and the steering committee will revise and finalise the consensus statements, and identify priority areas for future consideration. The steering committee was initiated and supported by the pharmaceutical company Lundbeck Ltd, through an educational grant. Lundbeck Ltd did not influence content.

Results

Results of the questionnaire and the evolution of the final consensus statements will be presented.

Disclosure of interest

The authors have not supplied their declaration of competing interest.

Type
EV552
Copyright
Copyright © European Psychiatric Association 2016
Submit a response

Comments

No Comments have been published for this article.